Hospital
Saint Francis Medical Center
Saint Francis Medical Center was paid $56.42M by Medicaid between Jan 2018 and Dec 2024, across 259 billing codes. Its largest line is Y7506, — 14% of everything it billed.
33Billing provider infoSAINT FRANCIS MEDICAL CENTER
CAPE GIRARDEAU, MO 63703
CAPE GIRARDEAU, MO 63703
33aNPI1467412726assigned 03/23/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$56.42M
24GClaims484,310
24DCodes billed259
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Missouri
Rank by total paid#5 of 74
Median peer was paid$4.44M
This provider vs. median13×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DAVISON, JUSTIN controls 19+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 66,537 | $17.67M | |
| 2019 | 71,039 | $17.52M | |
| 2020 | 48,001 | $5.92M | |
| 2021 | 57,809 | $2.03M | |
| 2022 | 75,559 | $3.74M | |
| 2023 | 86,950 | $5.07M | |
| 2024incomplete | 78,415 | $4.47M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| Y7506 | 14% | 22,166 | 19,043 | $7.64M | |
| X4011 | State-specific procedure code | 12% | 24,093 | 22,472 | $6.93M |
| Y7507 | 9.5% | 10,540 | 8,869 | $5.34M | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 5.8% | 52,278 | 46,460 | $3.26M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.7% | 53,704 | 46,677 | $3.22M |
| 80053 | Comprehensive metabolic panel | 5.2% | 51,383 | 45,323 | $2.92M |
| J3490 | Unclassified drugs | 4.8% | 6,583 | 3,591 | $2.71M |
| X4006 | 4.4% | 2,814 | 2,484 | $2.46M | |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.0% | 15,081 | 13,992 | $2.25M |
| 81001 | 3.7% | 20,938 | 19,609 | $2.06M | |
| X4003 | 3.1% | 15,181 | 12,531 | $1.73M | |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.5% | 12,217 | 11,687 | $1.44M |
247 more codes
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 2.1% | 3,537 | $1.20M |
| 94761 | 2.1% | 17,753 | $1.17M | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.3% | 7,335 | $753K |
| 88304 | 1.3% | 357 | $738K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.2% | 12,755 | $663K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.1% | 5,551 | $625K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,864 | $394K |
| 62323 | <1% | 1,687 | $360K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,236 | $350K |
| 85610 | <1% | 2,590 | $349K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 4,573 | $344K |
| 59025 | Fetal non-stress test | <1% | 1,477 | $338K |
| 85730 | <1% | 2,154 | $319K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,710 | $261K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,912 | $249K |
| 71045 | Radiologic examination, chest; single view | <1% | 4,564 | $238K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,398 | $221K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 238 | $212K |
| 84484 | <1% | 4,284 | $210K | |
| 83605 | <1% | 2,181 | $201K | |
| 83690 | <1% | 2,180 | $181K | |
| G0378 | Hospital observation service, per hour | <1% | 281 | $173K |
| 82550 | <1% | 2,169 | $156K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 3,106 | $148K |
| 86141 | <1% | 3,679 | $146K | |
| 88342 | <1% | 1,198 | $145K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 4,239 | $142K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,264 | $135K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 666 | $134K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 479 | $133K |
| 87581 | <1% | 1,497 | $128K | |
| 87486 | <1% | 1,497 | $128K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,136 | $127K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 2,829 | $126K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,569 | $114K |
| 92523 | <1% | 518 | $113K | |
| 20610 | <1% | 2,027 | $113K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,041 | $112K |
| 87088 | <1% | 3,153 | $108K | |
| 97165 | <1% | 363 | $96K | |
| 87040 | <1% | 1,015 | $96K | |
| 97161 | <1% | 236 | $90K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 673 | $89K |
| 87631 | <1% | 449 | $89K | |
| 87070 | <1% | 3,742 | $88K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 24 | $85K |
| 82553 | <1% | 911 | $82K | |
| 36591 | <1% | 1,510 | $81K | |
| 85027 | <1% | 647 | $78K | |
| 84145 | <1% | 1,953 | $76K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 642 | $66K |
| 95811 | <1% | 130 | $63K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 4,127 | $62K |
| 87660 | <1% | 859 | $57K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,271 | $51K |
| 83880 | <1% | 795 | $48K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 198 | $47K |
| 97597 | <1% | 1,281 | $44K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 618 | $43K |
| 84439 | <1% | 1,580 | $42K | |
| 87400 | <1% | 290 | $41K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 244 | $41K |
| 87480 | <1% | 486 | $40K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 442 | $40K |
| 88312 | <1% | 295 | $39K | |
| 87510 | <1% | 358 | $39K | |
| 83655 | <1% | 4,491 | $36K | |
| 81025 | <1% | 79 | $34K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 94 | $32K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 55 | $32K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 445 | $32K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 212 | $29K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,511 | $28K |
| 93296 | <1% | 2,873 | $26K | |
| 90698 | <1% | 1,130 | $25K | |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | <1% | 54 | $23K |
| 64483 | <1% | 67 | $23K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 134 | $22K |
| 99285 | Emergency room visit (most serious) | <1% | 81 | $22K |
| 43248 | <1% | 57 | $20K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 1,406 | $19K |
| 88313 | <1% | 337 | $19K | |
| 62321 | <1% | 52 | $19K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 303 | $18K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 540 | $18K |
| 84703 | <1% | 989 | $18K | |
| 20605 | <1% | 202 | $18K | |
| 43235 | <1% | 28 | $16K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 162 | $16K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 162 | $16K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 203 | $15K |
| 87641 | <1% | 28 | $13K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 30 | $13K |
| 82728 | <1% | 990 | $12K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 54 | $12K |
| 82150 | <1% | 81 | $12K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 228 | $11K |
| 45384 | <1% | 12 | $11K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 155 | $11K |
| 80061 | Lipid panel | <1% | 1,033 | $10K |
| 86803 | <1% | 253 | $10K | |
| 80081 | <1% | 139 | $10K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,652 | $10K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 187 | $10K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 279 | $10K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 15 | $10K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 47 | $9K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 379 | $9K |
| 11045 | <1% | 1,024 | $9K | |
| 83970 | <1% | 366 | $9K | |
| Q3014 | Telehealth originating site facility fee | <1% | 492 | $7K |
| 82607 | <1% | 350 | $7K | |
| 86235 | <1% | 136 | $7K | |
| 87210 | <1% | 26 | $7K | |
| 85651 | <1% | 2,177 | $7K | |
| 83540 | <1% | 904 | $6K | |
| 20553 | <1% | 45 | $6K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 63 | $6K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 590 | $6K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 42 | $6K |
| 94726 | <1% | 40 | $5K | |
| 87081 | <1% | 111 | $5K | |
| 83550 | <1% | 798 | $5K | |
| 95831 | <1% | 185 | $5K | |
| 87077 | <1% | 610 | $5K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 51 | $4K |
| 71250 | <1% | 135 | $4K | |
| 81002 | <1% | 1,446 | $4K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 40 | $4K |
| 90670 | <1% | 582 | $4K | |
| 86703 | <1% | 109 | $4K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 2,885 | $4K |
| 87340 | <1% | 86 | $4K | |
| 86762 | <1% | 72 | $3K | |
| 87186 | <1% | 441 | $3K | |
| 77336 | <1% | 84 | $3K | |
| 82950 | <1% | 122 | $3K | |
| 95813 | <1% | 12 | $3K | |
| 84425 | <1% | 118 | $3K | |
| 77065 | Tomosynthesis, mammo | <1% | 42 | $3K |
| 95832 | <1% | 102 | $3K | |
| 83735 | <1% | 140 | $2K | |
| 86300 | <1% | 203 | $2K | |
| 80047 | <1% | 27 | $2K | |
| 94060 | <1% | 15 | $2K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 58 | $2K |
| 90686 | <1% | 492 | $2K | |
| 86592 | <1% | 95 | $2K | |
| 84630 | <1% | 100 | $2K | |
| 82525 | <1% | 87 | $2K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 13 | $2K |
| 84702 | <1% | 153 | $2K | |
| 86039 | <1% | 261 | $2K | |
| 81511 | <1% | 16 | $2K | |
| 88142 | <1% | 62 | $2K | |
| 80074 | <1% | 39 | $2K | |
| 90633 | <1% | 218 | $1K | |
| 84681 | <1% | 123 | $1K | |
| 86200 | <1% | 193 | $1K | |
| 72131 | <1% | 29 | $1K | |
| 96415 | <1% | 146 | $1K | |
| 84480 | <1% | 170 | $1K | |
| 90744 | <1% | 221 | $1K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 30 | $1K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 14 | $1K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 13 | $1K |
| 76830 | Ultrasound, transvaginal | <1% | 13 | $1K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 19 | $1K |
| 90677 | <1% | 112 | $1K | |
| 95861 | <1% | 26 | $1K | |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | <1% | 12 | $1K |
| 80076 | <1% | 15 | $1K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 68 | $968.47 |
| 83615 | <1% | 368 | $956.98 | |
| 90681 | <1% | 98 | $944.14 | |
| 80069 | <1% | 229 | $850.14 | |
| 83525 | <1% | 122 | $843.04 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 15 | $827.55 |
| 76642 | <1% | 15 | $762.90 | |
| 90656 | <1% | 111 | $748.16 | |
| 86780 | <1% | 69 | $735.18 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 26 | $704.88 |
| 86900 | <1% | 12 | $656.34 | |
| 86800 | <1% | 13 | $599.62 | |
| 84432 | <1% | 13 | $589.12 | |
| C9399 | Unclassified drugs or biologicals | <1% | 225 | $560.93 |
| 82533 | <1% | 55 | $552.71 | |
| 82043 | <1% | 199 | $547.16 | |
| 93299 | <1% | 171 | $538.47 | |
| 96417 | <1% | 14 | $530.96 | |
| 87522 | Neg quan hep c or qual rna | <1% | 14 | $521.32 |
| 80050 | General health panel | <1% | 14 | $412.65 |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,500 | $393.85 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 157 | $390.52 |
| 72100 | <1% | 13 | $362.63 | |
| 86757 | <1% | 13 | $353.96 | |
| 85045 | <1% | 189 | $336.79 | |
| 86225 | <1% | 30 | $320.63 | |
| 93016 | <1% | 95 | $287.11 | |
| 90707 | <1% | 12 | $280.98 | |
| 87640 | <1% | 27 | $280.70 | |
| 86850 | <1% | 12 | $279.43 | |
| 86431 | <1% | 73 | $255.97 | |
| 86430 | <1% | 57 | $233.46 | |
| 85652 | <1% | 160 | $213.39 | |
| 86901 | <1% | 12 | $203.17 | |
| 93018 | <1% | 95 | $190.97 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 38 | $175.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 21 | $170.09 |
| 80164 | <1% | 13 | $168.18 | |
| 84156 | <1% | 91 | $156.72 | |
| 82378 | <1% | 13 | $150.12 | |
| 85014 | <1% | 98 | $138.33 | |
| 85018 | <1% | 110 | $138.33 | |
| 83721 | <1% | 15 | $125.57 | |
| 82746 | <1% | 12 | $98.42 | |
| 90716 | <1% | 12 | $93.75 | |
| 86666 | <1% | 12 | $93.08 | |
| 90680 | <1% | 12 | $75.26 | |
| 84436 | <1% | 39 | $69.00 | |
| 82570 | <1% | 20 | $68.06 | |
| 88311 | <1% | 40 | $67.80 | |
| 86140 | <1% | 74 | $65.96 | |
| J2704 | Injection, propofol, 10 mg | <1% | 840 | $64.92 |
| 84550 | <1% | 17 | $55.40 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 12 | $54.33 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 62 | $34.24 |
| 86038 | <1% | 14 | $32.64 | |
| 82948 | <1% | 16 | $16.12 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 1,060 | $0.00 |
| A6209 | Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | 0% | 94 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 146 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 267 | $0.00 |
| 99152 | 0% | 12 | $0.00 | |
| 99215 | Doctor's office visit, returning patient (complex) | 0% | 155 | $0.00 |
| 90710 | 0% | 12 | $0.00 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 13 | $0.00 |
| 94729 | 0% | 12 | $0.00 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 160 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 1,138 | $0.00 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 587 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 107 | $0.00 |
| G0453 | Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | 0% | 12 | $0.00 |
| 87807 | 0% | 18 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 149 | $0.00 |
| A9585 | Injection, gadobutrol, 0.1 ml | 0% | 27 | $0.00 |
| 94760 | 0% | 33 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAVISON, JUSTIN (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Saint Francis Medical Center | Poplar Bluff, MO | $7.48M |
| Saint Francis Medical Center | Sikeston, MO | $4.71M |
| Saint Francis Medical Center | Cape Girardeau, MO | $2.14M |
| Saint Francis Medical Center | Piedmont, MO | $2.10M |
| Saint Francis Medical Center | Dexter, MO | $1.08M |
| Saint Francis Medical Center | East Prairie, MO | $1.08M |
| Saint Francis Medical Center | Poplar Bluff, MO | $961K |
| Saint Francis Medical Center | Poplar Bluff, MO | $903K |
| Saint Francis Medical Center | Sikeston, MO | $530K |
| Saint Francis Medical Center | Charleston, MO | $484K |
| Saint Francis Medical Center | Jackson, MO | $311K |
| Saint Francis Medical Center | Scott City, MO | $288K |
| Saint Francis Medical Center | Jackson, MO | $177K |
| Saint Francis Medical Center | Cape Girardeau, MO | $106K |
| Saint Francis Medical Center | Dexter, MO | $56K |
| Saint Francis Medical Center | Jackson, MO | $37K |
| Saint Francis Medical Center | Charleston, MO | $17K |
| Saint Francis Medical Center | East Prairie, MO | $14K |
| Saint Francis Medical Center | Scott City, MO | $10K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.